The Mayo Clinic Experience With the Neurological Complications of the CTLA-4 Inhibitor Ipilimumab

We describe our institution’s experience with ipilimumab and illustrate 2 cases of presumed autoimmune neurological phenomenon resulting from its use.

Source: The Neurologist - May 1, 2018 Category: Neurology Tags: Case Report/Case Series Source Type: research